MGI Launches New Gene Sequencing Platforms at Medlab Middle East 2023

Ltd. (Shenzhen, China) is introducing its latest gene sequencing platforms at Medlab Middle East 2023, taking place 6-9 February in Dubai. The three new products being launched at Medlab Middle East by MGI includes DNBSEQ-G99, its latest gene sequencer with a mid to low range throughput, DNBSEQ-E25, a portable sequencer with a very low throughput, the DNBelab-D4 digital sample preparation system. In addition, the company is also displaying its MGISP-100 automated sample preparation system for visitors at its booth.

As one of the sequencers with the fastest speed among those with the same throughput in the world, DNBSEQ-G99 is based on MGI's core DNBSEQTM sequencing technology. It is the first sequencer to adopt triangular matrix signal spots on sequencing flow cell, among other innovations in biochemistry, optics, fluidics, temperature control and more, reaching higher density of data output, with an overall throughput of 8-48 Gb per run. DNBSEQ-G99 is especially suitable for targeted gene sequencing and small genome sequencing, requiring only 12 hours to finish PE150 sequencing.

DNBSEQ-E25, the flagship product in the E-series, is a portable, accessible, and user-friendly sequencer that features a data throughput of up to 7.5G daily. Built on the newly designed self-luminous biochemical system, DNBSEQ-E25 has upgraded its sequencing system, flowcells and sequencing cartridge. Equipped with built-in bioinformatics, it is designed to run sequencing and generate analysis reports on the go. Its ease of setup means it is ready to run in ten minutes, coupled by a quick turnaround time that takes only 20 hours from sample to FASTQ data.

Lastly, DNBelab-D4 is the first digital microfluidic automation platform developed by MGI. The portable digital sample preparation system can prepare samples from DNA to DNB on a single sample prep card. Meanwhile, it integrates the quantification function for automatic quantification after DNB preparation is completed, eliminating the need for manual quantification. Currently, DNBelab-D4 is mainly used for library preparation for high-throughput sequencing applications such as metagenomics sequencing of unknown pathogens. It can also cater to the requirements of different research and medical applications.

"We are excited to launch three new products at MEDLAB Middle East, including DNBSEQ-G99, our latest model of gene sequencer with mid to low range throughput, DNBSEQ-E25, a portable sequencer with very low throughput, as well as DNBelab-D4 digital sample preparation system. In addition, our MGISP-100 automated sample preparation system will be on display for visitors interested to learn more," said Dr. Roy Tan, General Manager of MGI Asia Pacific. "Once again, MGI showcases the commitment to supporting healthcare, scientific research and applications across the Middle East through our genomic technologies."

Related Links:
MGI Tech Co. Ltd.